EDAP TMS $28 million follow-on offering
We advised the underwriters on the equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Lannett Company $350 million senior secured notes offering
We advised the initial purchasers on the high-yield notes offering
Recursion Pharmaceuticals $500 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Charles River Laboratories International $1 billion senior notes offering
We advised Charles River Laboratories on the high-yield debt offering
AVITA Medical $69.1 million follow-on offering
We advised the underwriters on the equity offering
Reckitt Benckiser Group acquisition of Biofreeze
We are advising RB on the acquisition
NeoGenomics $230 million stock and $345 million convertible notes offerings
We advised the joint book-running managers on the public offerings of stock and convertible notes
Berkeley Lights $258 million secondary offering
Davis Polk advised the representatives of the several underwriters in connection with the $258 million SEC-registered offering of 3,000,000 shares of common stock of Berkeley Lights,…
NovoCure $575 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by NovoCure Limited of $575 million aggregate principal amount of its 0.000%…
Allakos $272 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the follow-on offering of 3,506,098 shares of common stock of Allakos Inc…